Paper27720719
History of antimicrobial drug discovery: Major classes and health impact.
Aminov R. Biochem Pharmacol, 2017. Cited by 158 papers, by iCite.
Cite this record
ConductScience Library. History of antimicrobial drug discovery: Major classes and health impact. Papers, record 27720719. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/27720719
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics5
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Anti-Bacterial Agents | Major topic |
| Bacterial Infections | Major topic |
| Drug Discovery | Major topic |
| Animals | |
| Humans |
Source PubMed
Cited by104
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 158 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42577513 | Knowledge, Attitudes, and Practices Regarding Antibiotic Use and Resistance Among University Students in Mogadishu: A Comparative Cross-Sectional Study. | Health Sci Rep | 2026 | https://conductscience.org/library/papers/42577513 | PubMed |
| 42347834 | Antibacterial drug discovery: challenges and preclinical promises from synthetic small molecules. | Chem Soc Rev | 2026 | https://conductscience.org/library/papers/42347834 | PubMed |
| 42192692 | Dual Analytical Evaluation of Generic Intravenous Vancomycin HCl in Saudi Arabia Using Microbiological and HPLC-DAD Approaches. | Antibiotics (Basel) | 2026 | https://conductscience.org/library/papers/42192692 | PubMed |
| 41902263 | Engineered Bacteriophages: A Next-Generation Platform for Precision Antimicrobials and Therapeutics. | Viruses | 2026 | https://conductscience.org/library/papers/41902263 | PubMed |
| 41767117 | New concept in wound infection management: From bacterial eradication to microbiome modulation. | APL Bioeng | 2026 | https://conductscience.org/library/papers/41767117 | PubMed |
| 41743030 | Containment of antimicrobial resistance for strengthening global public health security: Biorisk management perspectives. | Biosaf Health | 2026 | https://conductscience.org/library/papers/41743030 | PubMed |
| 41597449 | Mechanisms of Pseudomonas aeruginosa Resilience Against Antibiotic Treatment and Outlooks of Emerging Treatment Strategies. | Medicina (Kaunas) | 2026 | https://conductscience.org/library/papers/41597449 | PubMed |
| 41403883 | Mechanistic roles and therapeutic potential of bacteriophages in inflammatory gastrointestinal diseases. | Microbiome Res Rep | 2025 | https://conductscience.org/library/papers/41403883 | PubMed |
| 41310159 | Fragment-based drug design of a bacterial kinase inhibitor capable of increasing the antibiotic sensitivity of clinical isolates. | Commun Chem | 2025 | https://conductscience.org/library/papers/41310159 | PubMed |
| 41254354 | Computational approaches to the in vitro antimicrobial potential of Streptomyces paradoxus E4-10 extract against multidrug-resistant bacteria and phytopathogenic fungi. | Int Microbiol | 2025 | https://conductscience.org/library/papers/41254354 | PubMed |
| 41097292 | The Regulation of the Albomycin and Desferrioxamine E Biosynthesis in Streptomyces globisporus bja209. | Molecules | 2025 | https://conductscience.org/library/papers/41097292 | PubMed |
| 40768526 | High prevalence of multidrug-resistant and ESBL-producing bacteria in a primary healthcare facility in Accra, Ghana: A cross-sectional study. | PLOS Glob Public Health | 2025 | https://conductscience.org/library/papers/40768526 | PubMed |
| 40755505 | Assessing the Antibiotic Resistance in Food Lactic Acid Bacteria: Risks in the Era of Widespread Probiotic Use. | Food Sci Nutr | 2025 | https://conductscience.org/library/papers/40755505 | PubMed |
| 40709459 | An Evaluation of Alternative Treatment Strategies in Mitigating Colistin Resistance: Targeting Plasmid Transfer Through the Use of Bambermycin or the Protein Coded by the Mcr-1 Gene With Antibodies and Streptomycin. | Vet Med Sci | 2025 | https://conductscience.org/library/papers/40709459 | PubMed |
| 40472054 | Community use of systemic antibiotics among individuals aged 15 and over in Brazil: A seven-year population-based cross-sectional study. | PLoS One | 2025 | https://conductscience.org/library/papers/40472054 | PubMed |
| 40284688 | Staphylococcus aureus Biofilm-Associated Infections: Have We Found a Clinically Relevant Target? | Microorganisms | 2025 | https://conductscience.org/library/papers/40284688 | PubMed |
| 40190594 | Knowledge, Attitude and Practice of Antimicrobial Usage Among Undergraduate Medical Students in Universities and Institutes, Thamar, Yemen. | Infect Drug Resist | 2025 | https://conductscience.org/library/papers/40190594 | PubMed |
| 40071214 | Detection of antimicrobial resistance via state-of-the-art technologies versus conventional methods. | Front Microbiol | 2025 | https://conductscience.org/library/papers/40071214 | PubMed |
| 39852081 | A Label-Free Aptasensor for the Detection of Sulfaquinoxaline Using AuNPs and Aptamer in Water Environment. | Biosensors (Basel) | 2025 | https://conductscience.org/library/papers/39852081 | PubMed |
| 39768868 | Antimicrobials in Orthopedic Infections: Overview of Clinical Perspective and Microbial Resistance. | Medicina (Kaunas) | 2024 | https://conductscience.org/library/papers/39768868 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/27720719
GET https://conductscience.org/api/papers/v1/27720719/cited_by?page=2